Telomir Pharmaceuticals TELO 深 滬
等待開盤 10-09 09:30:00 美东时间
1.65
-0.150
-8.33%
華盛通- 最 高1.74
- 今 開1.70
- 成交量 1065.97万股
- 最 低 1.57
- 昨 收 1.80
- 總市值 4910.85万
- 52周最高 7.0791
- 市盈率 靜 --
- 換手率 35.82%
- 52周最低 1.12
- 委 比 -81.83%
- 總股本 2976.27万
- 歷史最高 20.72
- 量 比 1.77
- 振 幅 9.44%
- 歷史最低 1.12
- 每 手 1
- 風險率 1.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Market-Moving News for October 7th
TMQ: 230% | Shares of mining companies that operate in Alaska are trading higher after President Trump signed an executive order to build a 211-mile access road to the Ambler Mining District. NAK: 49% |
10-07 19:20
What's going On With AppLovin Shares After Hours?
AppLovin shares fell after the SEC launched an investigation into the company's data-collection practices amid multiple short-seller allegations.
10-07 13:08
Telomir Pharmaceuticals Announces Promising Preclinical Findings
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has shared an update. On October 6, 2...
10-07 04:38
Telomir Pharmaceuticals Reports Telomir-1 Resets DNA Methylation Of Tumor Suppressor Genes Implicated In Two Of The Most Persistent Challenges In Oncology, Metastasis And Treatment Resistance
Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Genes Implicated in Two of the Most Persistent Challenges in
10-07 04:20
Tesla Co-Founder Takes On Elon Musk, Jeff Bezos With Plans For $41,000 Electric Truck
A Tesla co-founder is back in the electric vehicle space and will be taking his former company head on with plans for an electric pickup truck on market in 2026.
09-25 07:09
Telomir Pharmaceuticals’ Telomir-1 Shows Broad-Spectrum Efficacy
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has shared an update. Telomir Pharmac...
09-18 19:56
Telomir Pharma Study Shows Telomir-1 Blocks Cancer-Linked Gene Regulators In Lab Tests
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) today announced new in vitro pharmacology results demonstrating that Telomir-1 potently inhibits three members of the KDM5 histone demethylase family. Histone demethylases are
09-18 19:35
Telomir Pharmaceuticals Reported New Preclinical Cancer Data In Aggressive Human Prostate Cancer Cell Models Showing That Telomir-1 Inhibited DNA Hypermethylation Of CDKN2A, A Master Tumor Suppressor Gene-8K Filing
CDKN2A plays a central role in controlling uninhibited cell growth and initiating programmed cell death, and its silencing is a well-established hallmark of cancer progression.Telomir-1 outperformed both Rapamycin and
09-09 19:49
Market-Moving News for August 28th
TELO: 61% | Telomir Pharmaceuticals shares are trading higher after the company reported results for Telomir-1. SNOW: 14% | Snowflake shares are trading higher after the company reported Q2 financial
08-28 19:17
Telomir Pharmaceuticals Inc Reports Telomir-1 Potently Inhibits UTX, A Key Histone Demethylase Involved In Regulating Gene Expression Through DNA Methylation
- SEC Filing Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the root mechanisms of cancer, aging, and age-related diseases, today announced
08-28 04:13
